Monday, 10 June 2019

Roche's combo lymphoma treatment wins FDA's accelerated approval

The U.S. Food and Drug Administration granted accelerated approval to Roche Holding AG's combo lymphoma treatment for previously treated patients, the company said on Monday


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)